Merit Medical Systems, Inc.
MMSIHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeMerit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United. With a market capitalization of $5.57B, it sits in mid-cap territory. It operates through two segments, Cardiovascular and Endoscopy.
Market Cap
$5.57B
Beta
0.51
P/E (TTM)
38.71
P/E (Fwd)
20.23
EPS (TTM)
$2.41
EPS (Fwd)
$4.61
ROE
9.2%
ROA
4.9%
Cash
$448.7M
Total Debt
$820.1M
Free CF
$173.9M
52W Change
12.8%
Annual Financials
Cash vs Debt
Where MMSI stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, MMSI finished 15.98% above its 150-day moving average ($75.15) and 13.62% above its 200-day moving average ($76.71). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MMSI overbought or oversold?
At the October 15, 2026 close, MMSI's RSI(14) was 49.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Merit Medical Systems, Inc. carries $820.1M in total debt against $448.7M in cash reserves — debt is roughly 1.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $173.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 9.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.15B (2022) to $1.52B (2025), reflecting a 32% increase over the period.
With a beta below 0.7, Merit Medical Systems, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Merit Medical Systems, Inc.'s trajectory.